Literature DB >> 7363930

Effects of a new diuretic (piretanide) compared with furosemide on renal diluting and concentrating mechanisms in patients with the nephrotic syndrome.

C Marone, F C Reubi.   

Abstract

The mode and site of action of the new diuretic agent piretanide were investigated in man. The effect of a single oral dose of 12 mg was compared with that of furosemide 80 mg p.o. iin 6 patients with the nephrotic syndrome. Piretanide showed a greater diuretic and natriuretic response than furosemide during maximal water diuresis, but the effect was similar in the hydropenic state. Like furosemide, piretanide decreased free water clearance relative to delivery during water diuresis and the reabsorption of solute-free water during hydropenia. This inhibitory action on both the concentrating and diluting urinary mechanisms demonstrates an effect of piretanide localized in the ascending limb of Henle's loop. Consistent alterations in glomerulur filtration rate, renal blood flow or filtration fraction were not observed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7363930     DOI: 10.1007/bf00561895

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  The effect of chlorothiazide on renal excretion of electrolytes and free water.

Authors:  H O HEINEMANN; F E DEMARTINI; J H LARAGH
Journal:  Am J Med       Date:  1959-06       Impact factor: 4.965

2.  THE SITE OF ACTION OF FUROSEMIDE AND OTHER SULFONAMIDE DIURETICS IN THE DOG.

Authors:  W SUKI; F C RECTOR; D W SELDIN
Journal:  J Clin Invest       Date:  1965-09       Impact factor: 14.808

3.  The effect of variations in solute excretion and vasopressin dosage on the excretion of water in the dog.

Authors:  J ORLOFF; H N WAGNER; D G DAVIDSON
Journal:  J Clin Invest       Date:  1958-03       Impact factor: 14.808

4.  Effect of furosemide on sodium reabsorption by proximal tubule of the dog.

Authors:  F G Knox; F S Wright; S S Howards; R W Berliner
Journal:  Am J Physiol       Date:  1969-07

5.  Localization of diuretic action from the pattern of water and electrolyte excretion.

Authors:  D W Seldin; G Eknoyan; W N Suki; F C Rector
Journal:  Ann N Y Acad Sci       Date:  1966-11-22       Impact factor: 5.691

6.  Clinical use of furosemide.

Authors:  F C Reubi
Journal:  Ann N Y Acad Sci       Date:  1966-11-22       Impact factor: 5.691

7.  [Comparative studies on the renal clearance of Na-Cr2Cr51 ethylenediaminetetraacetate, inulin and sodium thiosulfate in humans].

Authors:  C Vorburger; H Riedwyl; F Reubi
Journal:  Klin Wochenschr       Date:  1969-04-15

8.  The mechanism of suppression of proximal tubular reabsorption by saline infusions.

Authors:  F C Rector; J C Sellman; M Martinez-Maldonado; D W Seldin
Journal:  J Clin Invest       Date:  1967-01       Impact factor: 14.808

9.  Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.

Authors:  C J Roberts; M Homeida; F Roberts; W Bogie
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

10.  An inhibitory effect of furosemide on sodium reabsorption by the proximal tubule of the rat nephron.

Authors:  B M Brenner; R I Keimowitz; F S Wright; R W Berliner
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808

  10 in total
  6 in total

1.  Comparison of the short-term effects of the loop diuretic piretanide and furosemide in patients with renal insufficiency.

Authors:  C Marone; F C Reubi; W Lahn
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  Kinetics of a high dose of piretanide in renal failure.

Authors:  J L Brazier; N Pozet; G Faucon; J Traeger; A Hadj-Haissa
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 3.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

4.  The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency.

Authors:  K J Berg; R A Walstad; K Bergh
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

5.  Pharmacokinetics of high doses of piretanide in moderate to severe renal failure.

Authors:  C Marone; F C Reubi; M Perisic; W Lahn
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Pharmacokinetics of the loop diuretic piretanide in renal failure.

Authors:  U Walter; A Röckel; W Lahn; A Heidland; W Heptner
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.